Back to Search

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age

River Forest, Illinois, 60305
Columbus, Georgia, 31904
New Orleans, Louisiana, 70115
Lakeland, Florida, 33805
Miami, Florida, 33186
Search open until 11/28/2024

The main purpose of this first-in-human study is to generate sufficient safety and immunogenicity data to enable the selection of an appropriate dose level for the initiation of a Phase 2/3 study.

Eligibility

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, learn about Clinical

Ages Eligible for Study Min Age: 50 years - Max Age: N/A
Sexes Eligible for Study All
Accepts Healthy Volunteers Yes

Visit ClinicalTrials.Gov for more information
Support nonprofit organizations through participating in clinical trials at no cost to you
You may also be interested in
Cincinnati, Ohio and more
A Study Looking at the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults at Risk for SARS-CoV-2
SARS-CoV Infection and more Read more
Rockville, Maryland and more
A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults
Seasonal Influenza Read more
Hollywood, Florida and more
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 18- to 30-Year-Old Healthy Adults
Epstein-Barr Virus Infection Read more